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Background: This study investigated the efficacy of low level laser therapy (LLLT) for managing alveolar osteitis 
(AO). 
Material and Methods: Sixty patients with alveolar osteitis of mandibular third molars were randomly divided into 
three groups. In group 1, socket irrigation was followed by alvogyl placement, and the treatment was repeated 
48 hours later. In group 2, socket was irradiated with a low power red laser for 3 consecutive days (200 mW, 30 
seconds on each of the buccal and lingual surfaces and 30 seconds at the middle of the socket, 6 J per area). The 
subjects in group 3 underwent treatment with a low power infrared laser with the same parameters as group 2. A 
visual analogue scale (VAS) was used to record the degree of pain at the morning (T0, before intervention) and at 
6 (T1) and 12 (T2) hours later for 3 days.
Results: Pain was significantly lower in the alvogyl group than the other groups at T1 and T2 points on day 1 and 
at T0 and T1 points on day 2 (p<0.05). At T2 point on day 2 and on day 3, VAS became significantly lower in the 
red laser group compared to the other groups (p<0.05). The infrared laser was not more efficacious than the other 
groups at any of the treatment intervals, but it reduced VAS to an acceptable level.
Conclusions: LLLT displayed good results in this study for treatment of alveolar osteitis and should be further 
investigated as an alternative to alvogyl for AO management.
Key words: Low level laser, low power laser, therapy, alvogyl, dry socket, alveolar osteitis, mandibular third 
molar.
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Introduction
Alveolar osteitis (AO) or dry socket is the most com-
mon complication of dental extraction. It occurs with 
the incidence of 1-4% after routine dental extractions 
(1,2), although its incidence may reach 30% following 
surgical removal of impacted mandibular third molars 
(2,3). The experience of an unbearable pain that is not 
easily alleviated with analgesics and the presence of an 
empty socket due to the degradation of blood clot are the 
characteristic features of this condition. Furthermore, 
marked halitosis, foul taste and regional lymphadenitis 
are frequently observed in patients affected with AO. 
The condition typically initiates 1-3 days after extrac-
tion and remains for 7 to 10 days, during which the 
socket is being covered with new granulation tissue (2). 
The most commonly reported risk factors for dry socket 
formation include age (2), gender (2), site of extraction 
(2), difficult extraction (4), smoking (5-8), pericoronitis 
(9), use of oral contraceptives (8-10) and menstrual cy-
cle (8,11). Despite all the measures that have been sug-
gested to prevent AO, this condition continues to occur 
in every dental practice and make the patients unsat-
isfied with the treatment results. Therefore, finding an 
ideal approach for managing dry socket is considered a 
subject of interest. 
Because of the severe pain, the treatment strategies for 
AO are mainly palliative and are based on attenuating 
patient’s pain/discomfort over the period that healing 
spontaneously occurs. However, accelerating the healing 
process should also be considered as the secondary aim 
of the treatment. A widely used dressing for management 
of AO is alvogyl which contains eugenol (analgesic and 
anti-inflammatory), iodoform (antimicrobial), and buta-
men (anesthetic) (12). Other therapeutic agents such as 
zinc oxide eugenol paste (13), SaliCept patch (12) or plas-
ma rich in growth factor (PRGF) with gelatin sponge (13) 
have also been used successfully for AO management. 
With introducing low power lasers, their applications 
have been remarkably increased in different aspects of 
dentistry including oral surgery procedures. Low level 
laser therapy (LLLT) has a proven efficacy in acceler-
ating the wound healing process (14,15), reducing pain 
(16,17) and shortening the duration of the inflammatory 
phases (16). These various biochemical effects of LLLT 
suggest that it may be a suitable treatment alternative 
to the conventional methods for managing dry socket, 
which can act not only by reducing pain but also through 
acceleration of the healing process.
There are only few studies regarding the effectiveness 
of LLLT in the treatment of dry socket and comparison 
of low power red and infrared lasers for this purpose has 
not been performed according to the authors’ knowl-
edge. Therefore, this study was conducted to compare 
the effects of low level red and infrared lasers and alvo-
gyl in managing patients affected with dry socket.
Material and Methods
The sample consisted of sixty patients affected with al-
veolar osteitis of mandibular third molars, who referred 
to the Department of Oral and Maxillofacial Surgery of 
Mashhad Dental School, Mashhad University of Medi-
cal Sciences, Mashhad, Iran. The patients were 34 fe-
males and 26 males with mean age of 35.3 years (age 
range 23 to 65 years). The inclusion criteria consisted of 
subjects with at least 18 years old age in whom the defi-
nite diagnosis of dry socket in a mandibular third molar 
was made by an oral and maxillofacial surgeon accord-
ing to the following criteria: the presence of severe pain 
in and around the socket initiated 1 to 3 days postopera-
tively, and the observation of an alveolar socket devoid 
of blood clot with exposed bone. The study design ex-
cluded patients who had a background of radiotherapy 
or were affected with systemic diseases that could inter-
act with the treatment process such as bone pathologic 
conditions, hematologic diseases, diabetes mellitus and 
etc. Furthermore, subjects who were smokers, affected 
with psychiatric disorders or had conditions that laser 
therapy could be contraindicated such as pregnancy 
were excluded from the sample. The protocol of the 
study was reviewed and approved by the Ethics Com-
mittee of Mashhad University of Medical Sciences, and 
each participant signed and informed consent document 
after being aware of the treatment process.
This was a prospective randomized clinical trial. The 
participants were divided into three groups of 20 each 
according to a random number table, and underwent the 
following treatments:
- Group 1 (Alvogyl): In this group, after local anesthe-
sia with 2% lidocaine combined with 1:100,000 epine-
phrine, the extraction socket was thoroughly irrigated 
with 0.9 % sterile saline solution to remove debris and 
bacteria from the denuded bone. Afterwards, a suf-
ficient amount of alvogyl (Septodont, France) was in-
serted within the socket. Saline irrigation was repeated 
48 hours later and alvogyl was refreshed.
- Group 2 (Low power red laser; LPRL): The patients 
in this group received treatment from a low power in-
dium-gallium-aluminum-phosphide (InGaAlP) diode 
laser (Thor DD2 control unit, Thor, London, UK) for 
3 consecutive days. The outcome of our pilot study (the 
data have not been presented) revealed that laser thera-
py on every other day resulted in severe pain experience 
between irradiations, so LLLT was performed on con-
secutive days. The apparatus emitted a wavelength of 
660 nm and operated at the power of 200 mW and con-
tinuous-wave mode. The irradiation was accomplished 
on three areas (buccal and lingual surfaces of the socket 
and at the middle of the socket) for 30 seconds each, 
delivering 6 J of energy per area. The energy density 
at the surface of the probe was calculated to be 85.7 J/
cm2 (surface area of the probe, 0.07 cm2). However, the 
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probe was held at an approximate distance of 1 cm and 
the beam was divergent, so the energy density at the 
target area would be lower than that calculated at the 
surface of the probe. Both patient and therapist wore 
safety goggles during treatment.
- Group 3 (Low power infrared laser; LPIL): The de-
vice used in this group was a low level gallium-alumi-
num-arsenide (GaAlAs) diode laser (Thor), emitting a 
wavelength of 810 nm. Similar to group 2, the laser was 
applied at the power of 200 mW and continuous-wave 
mode and irradiation was performed for 30 seconds 
on each target area (buccal and lingual surfaces of the 
socket and at the middle of the socket). The energy of 6 
J was delivered per area, with energy density of 21.4 J/
cm2 considering the spot size of 0.28 cm2 at the surface 
of the probe.  However, the laser handpiece was approx-
imately 1 cm far from the target area and so the actual 
energy density would be lower than that calculated at 
the probe surface. The patients attended therapy for 3 
consecutive days and eye protection was taken with 
safety goggles. 
-Outcome assessment
The patients were followed-up for 3 days after diag-
nosis and initiating treatment measures. Each patient 
was requested to record the pain level experienced at 
the morning (T0, before intervention) and at 6 (T1) and 
12 (T2) hours later for 3 days. A visual analogue scale 
(VAS) was used to quantify pain, consisting of a 10-
cm horizontal scale, with 0 (the left side) indicating the 
absence of pain and 10 (the right side) representing the 
most severe pain possible. Additional follow-ups were 
set for some patients if required.
-Statistical analysis
The Kolmogorov-Smirnov test indicated that the pain 
data relating to the first day of the experiment were nor-
mally distributed (p>0.05), while those of days 2 and 
3 were not (p<0.05). Therefore, a repeated measures 
analysis was run to detect any significant differences 
in pain intensity between the study groups and between 
the different evaluation times in each group on day 1. 
For days 2 and 3, the Kruskal-Wallis test, Mann-Whit-
ney U test (with Bonferroni correction), Friedman test 
and Wilcoxon signed-rank test were used for inter- and 
intra-group comparisons of pain level. The statistical 
calculation was performed by SPSS (Statistical Package 
for Social Sciences, Version 16.0, SPSS Inc, Chicago, 
IL) software, and the significance level was determined 
at p<0.05.
Results
- Comparison of pain intensity between the different 
evaluation times in each group
-Day 1
The repeated measures analysis revealed significant dif-
ferences in VAS scores between the different evaluation 
times in each group (p<0.001). Figure 1 represents vari-
ations of pain intensity in the study groups before in-
tervention (T0) and at 6 (T1) and 12 hours (T2) later on 
day 1. The alvogyl group showed a remarkable decrease 
in pain after 6 hours of intervention (p<0.05) with no 
significant alteration between 6 and 12 hours later. Both 
laser groups also showed significant decreases in VAS 
scores after 6 hours of intervention (p<0.05). Between 
T1 and T2 time points, VAS significantly decreased in 
the LPRL group (p<0.05), but in the LPIL group, a neg-
ligible increase in pain occurred (Fig. 1).
-Day 2 
The Friedman test revealed significant differences in 
pain between the different treatment intervals in each 
group (p<0.05). Figure 2 demonstrates variations of 
VAS scores in the study groups at T0 and at 6 (T1) and 
12 hours (T2) later on day 2. Pain was slightly but sig-
nificantly worsened in the alvogyl group between T0-T2 
and T1-T2 time points (p<0.05). On the other hand, there 
was a significant reduction in painful symptoms after 
6 hours of intervention in both laser groups (p<0.05), 
Fig. 1. A line chart indicating VAS values in the study groups 
at different evaluation times on day 1. Significant differences 
were found between T0-T1 and T0-T2 in the alvogyl and LPIL 
groups and between T0-T1, T0-T2 and T1-T2 in the LPRL group 
(p<0.05).
Fig. 2. A line chart indicating VAS values in the study groups at 
different evaluation times on day 2. Significant differences were 
found between T0-T2 and T1-T2 in the alvogyl group (pain wors-
ening), between T0-T1, T0-T2 and T1-T2 in the LPRL group and 
between T0-T1 and T0-T2 in the LPIL group (p<0.05). 
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which continued until T2 time point in the LPRL group 
(Fig. 2).
-Day 3
The Friedman test indicated significant differences in 
pain between the different evaluation times in each 
group (p<0.05). The variations of VAS scores on day 
3 are demonstrated in figure 3. All groups experienced 
significant decreases in painful symptoms between 
the treatment intervals (p<0.05) with the exception of 
LPRL group between T1-T2 time points (p>0.05). The 
LPRL group was the only one that completed the study 
period with a pain value near zero (Fig. 3).
- Comparison of pain intensity between the study groups 
at each treatment interval 
-Day 1
Fig. 4 compares the VAS scores of the study groups 
at different time points on day 1. Analyzing the data 
with repeated measures analysis reveled a significant 
interaction between the two variables of time and group 
(p<0.001), so one way analysis of variance (ANOVA) 
was run to compare pain intensity among the study 
groups at each treatment interval. The results showed 
that the pretreatment pain (T0) was not significantly dif-
ferent among the groups (p=0.509), but at both 6 (T1) 
and 12 (T2) hours after intervention, significant be-
tween-group differences were found (p<0.001). Tukey 
pairwise comparison test revealed that at both T1 and 
T2, pain was significantly lower in the alvogyl group 
compared to the red and infrared laser groups (p<0.05). 
At T1, the two laser groups were not significantly dif-
ferent from each other, but at T2, pain was significantly 
lower in the red compared to the infrared laser group 
(p<0.05; Fig. 4).
-Day 2
Figure 5 presents comparison of VAS scores among the 
study groups at different time points on day 2. Significant 
differences were found in VAS scores among the study 
groups at all treatment intervals on day 2 (p<0.001). Pair-
wise comparisons indicated that at T0, pain was signifi-
cantly lower in the alvogyl group than the red laser group, 
which in turn showed significantly lower pain than the 
infrared laser group (p<0.01). At T1, the mean VAS was 
significantly lower in the alvogyl than both laser groups 
(p<0.01), which were not significantly different from 
each other. At T2, the VAS became significantly lower 
in the red laser group than the other groups, and it was 
significantly lower in the alvogyl group than the infrared 
laser group (p<0.01; Fig. 5).
-Day 3 
Comparison of VAS scores among the study groups on 
day 3 is presented in figure 6. There were significant 
between-group differences in VAS scores at all treat-
ment intervals on day 3 (p<0.001). The Mann Whitney 
U test indicated that at T0, T1 and T2, pain intensity in 
the red laser group was significantly lower than both 
the alvogyl and infrared laser groups, and in the alvogyl 
group, it was significantly lower than the infrared laser 
group (p<0.01; Fig. 6). 
Fig. 4. Comparison of pain intensity among the study groups 
on day 1. Significant differences were found between Alvogyl 
and both laser groups at T1, and between all the study groups 
at T2 (p<0.05). 
Fig. 5. Comparison of pain intensity among the study groups 
on day 2. Significant differences were found between all the 
study groups at T0 and T2 time points, and between Alvogyl 
and both laser groups at T1 (p<0.01). 
Fig. 3. A line chart indicating VAS values in the study groups 
at different evaluation times on day 3. Significant differences 
were found between T0-T1, T0-T2 and T1-T2 in the alvogyl and 
LPIL groups and between T0-T1 and T0-T2 in the LPRL group 
(p<0.05).
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Discussion
The present study compared the clinical outcomes of 
low level red and infrared lasers with that of alvogyl for 
the treatment of dry socket. Alvogyl was employed fol-
lowing socket irrigation on the first and third days of the 
experiment and caused a rapid alleviation of pain.  On 
the first day, the mean VAS decreased from 7.81 to 2.45 
degree (69 % improvement) after 6 hours, while be-
tween 6 and 12 hours of intervention, it decreased from 
2.45 to 2.25 (8 % improvement). On the second day, the 
degree of pain increased 4% and 18% after 6 hours and 
between 6 and 12 hours of initial examination, respec-
tively. Although pain worsening was small in the alvo-
gyl group on day 2, it reached statistical significance 
between T1-T2 and T0-T2 time points. On the third day, 
the mean VAS significantly decreased after refreshing 
the dressing, so that pain improved 74% within the first 
6 hours and about 53% between 6 and 12 hours of inter-
vention. The effectiveness of dressings containing eug-
enol in management of patients with postoperative pain 
has been reported in previous studies (1,18). The lower 
efficacy of alvogyl in decreasing pain between 6 and 12 
hours of intervention and also its lack of effect on day 2 
indicate that although alvogyl lessens patients’ pain im-
mediately, but its effect is not maintained over time.
In the second group of this study, the application of 660 
nm laser caused a significant reduction in pain over the 
course of the experiment. Although the improvement 
was more evident in the first 6 hours after irradiation, 
but there was also a remarkable improvement between 
6 and 12 hours later, implying that the biomodulative ef-
fects of LPRL remain for several hours after its applica-
tion. On day 1, VAS decreased from 8.21 to 5.35 degree 
(35% improvement) after 6 hours of intervention, and 
from 5.35 to 4.42 (17% improvement) between 6 and 12 
hours later. On day 2, VAS improved 41% and 47% after 
6 hours and between 6 and 12 hours of laser therapy, 
respectively. The VAS scores on day 3 were near zero 
and were the lowest among the study groups.
LLLT was performed with an 810 nm infrared laser in 
the third group of this experiment. On the first day, pain 
decreased 38% (VAS reduction from 8.11 to 5.05 de-
gree) after the first  6 hours of laser application, while 
between 6 and 12 hours later, not only pain reduction 
stopped but also there was 7% worsening in the pain 
experienced by the patients. The VAS improved 40% 
following 6 hours, and 5% between 6 and 12 hours of ir-
radiation on day 2. The corresponding values were 57% 
and 45% on day 3. The total amount of reduction in VAS 
scores on days 1, 2 and 3 was 2.7, 3.1 and 4 degree, re-
spectively, which means that the efficacy of the 810 nm 
diode laser increased over time. 
Comparison of pain intensity among the study groups 
revealed that on the first day, pain was significantly 
lower in the alvogyl group than the other groups at both 
6 and 12 hours after intervention. This difference also 
existed at T0 and T1 time points on day 2, when signifi-
cantly lower pain was experienced by the patients in the 
alvogyl group compared to the other groups. This can 
be attributed to the presence of the dressing that could 
fill the empty socket and in this way prevent from stim-
ulation of denuded bone, which is one of the main fac-
tors producing pain. Furthermore, the dressing contains 
analgesic and local anesthetic factors that can act imme-
diately and reduce patients’ pain. However, the presence 
of a dressing within the extraction socket could also be 
associated with delayed healing (19). 
The order of pain intensity changed after 12 hours of 
intervention on day 2, so that the mean VAS became 
significantly lower in the red laser group than the other 
groups. The significantly lower pain intensity in the 
LPRL group continued at all treatment intervals on day 
3 compared to the LPIL and alvogyl groups. These re-
sults indicate that the alveogyl has a more immediate ef-
fect than LLLT on reducing pain of the patients affected 
with dry socket, but  after 12 hours of intervention on 
day 2 and at all treatment intervals on day 3, the 660 nm 
laser became more efficacious than the alvogyl for pain 
reduction. This may be related to the fact that LLLT is 
not only capable to reduce pain and inflammation, but 
also can increase the rate and quality of wound healing 
(14,15). The effect on wound healing can be achieved 
by several mechanisms such as stimulating the prolif-
eration of fibroblasts (20), enhanced epithelization (21), 
improved organization and maturation of collagen fib-
ers (14,22) and increased matrix synthesis and angio-
genesis (14).
The infrared laser did not perform more effectively than 
the other groups at any of the treatment evaluations, but 
it caused a significant decrease in VAS scores during the 
3-day treatment course, so that pain reached an accept-
able value (VAS =1.2 degree) at the end of the experi-
ment. It is possible that with repetitious use of this laser 
on the next days or with alteration in laser parameters, 
Fig. 6. Comparison of pain intensity among the study groups on 
day 3. Significant differences were found between all the study 
groups at T0, T1 and T2 (p<0.01).
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its efficacy would be improved, but further studies are 
warranted for verification.
It should be noted that in the control (alvogyl) group, 
the socket was gently irrigated with normal saline solu-
tion before placing alvogyl in order to remove debris 
and bacteria. In the LLLT groups, however, socket ir-
rigation was not performed in order to eliminate the 
need for local anesthesia and to accelerate the treatment 
process. Furthermore, since no material was inserted in 
the socket, irrigation seemed to be not obligatory. Treat-
ment of dry socket is a time-consuming process for both 
the surgeon and patient, which may require several ap-
pointments for refreshing the dressing. We aimed to 
reach an effective approach that could be accomplished 
by a laser therapist or a dental assistant without the need 
to interact with routine activities in the dental office. It 
is possible, however, that socket irrigation before laser 
therapy would improve the treatment outcomes, but fur-
ther studies are required to elucidate this issue.
There are few studies regarding the effectiveness of 
LLLT in the treatment of AO. Jovanovic et al. (23) eval-
uated the effectiveness of low level laser therapy in pain 
relief and healing of extraction wounds with alveolar 
osteitis and reported that the LLLT group experienced 
significantly lower pain on days 5 to 8 after intervention 
compared to a control group in which a dressing of zinc 
oxide eugenol paste was applied. Kaya et al. (12) indi-
cated that LLLT with an 808 nm diode laser at 7.64 J/
cm2 performed quickly and superiorly compared to the 
alvogyl and SaliCept patch for the management of AO. 
The outcomes of this study are in contrast with those of 
Kaya et al. (12), because the LPIL group showed lower 
efficacy than the alvogyl group in pain reduction. This 
can be attributed to the use of different laser parameters 
in this study compared to that of Kaya et al. (12) or to 
the lack of socket irrigation in the laser groups of this 
study, while Kaya et al, performed curettage and irriga-
tion in all of the study groups. If the current study was 
continued for a longer time, it was possible that the dif-
ference between the LPIL and the other groups would 
be insignificant. However, the immediate effect of the 
treatment modalities for dry socket should be consid-
ered more important than their delayed effect. 
By comparing the effect of the two laser wavelengths 
used in this study, it was revealed that the red laser per-
formed significantly better than the infrared laser at all 
treatment intervals, especially on days 2 and 3 of the 
experiment. This may be related to the high efficacy 
of the red laser wavelength for enhancing the wound 
healing process. The red laser is mainly absorbed in the 
first 7-8 mm of the tissue, while the penetration depth 
of the infrared laser reaches 2-3 cm. It seems that re-
garding dry socket, the surface absorption of laser en-
ergy is more important than its deep penetration into 
the alveolar bone. Another variable that could be im-
portant in the treatment results of low power lasers is 
the energy delivered to the target tissue and the energy 
density (dosage) (24). In both groups of LLLT, 6 J of 
energy was delivered to each area (18 J in total). The en-
ergy densities at the surface of the probes in this study 
were 85.6 J/cm2 for the red laser and 21.4 J/cm2 for the 
infrared laser groups. The dosage of the red laser was 
several times greater than the infrared laser and this 
can contribute to the different outcomes obtained with 
these two wavelengths. Bjordal et al. (16) believed that 
achieving analgesic and anti-inflammatory effects from 
infrared lasers requires at least 6 J/cm2 of energy den-
sity for small wounds and 10 J/cm2 for large wounds. 
However, in situations such as this study in which the 
laser is irradiated from above the socket and the target 
tissue has a relatively large distance from the probe, the 
exact calculation of energy density at the target area 
is not possible. The anatomic variations of the socket 
among patients, the invisible nature of the infrared la-
ser, and the reduction in energy density because of the 
divergence of the beam contribute to this problem. 
The limitation of this study was the short follow-up 
period. Further studies with longer follow-ups are war-
ranted to find the optimum parameters of low power 
lasers and to evaluate the combined effects of red and 
infrared lasers in reducing pain and accelerating the 
healing process in patients affected with dry socket.
Conclusions
Under the conditions used in this study.
1- The immediate effect of the alvogyl in reducing pain 
of the patients affected with dry socket was significantly 
greater than the low power red and infrared lasers, but 
after 12 hours of intervention on day 2 and at all treat-
ment intervals on day 3, the 660 nm laser became more 
effective. Therefore, the low level red laser should be 
further investigated as an alternative to alvogyl in the 
management of AO.
2- Although pain significantly decreased in the 810 nm 
laser group over time, its performance was not better 
than either the alvogyl or the 660 nm laser groups at any 
of the treatment intervals.
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